Efficacy and Safety of Sacituzumab in Patients With OCCC After Immunotherapy Progression

Clinical trial NCT07168083 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07168083
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Ovarian Cancer Antibody-drug Conjugates Clear Cell Adenocarcinoma of Ovary

Start date: 2026-09-01
Primary completion: 2027-08-31
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.